- 阻害剤
- 研究分野別
- PI3K/Akt/mTOR
- Epigenetics
- Methylation
- Immunology & Inflammation
- Protein Tyrosine Kinase
- Angiogenesis
- Apoptosis
- Autophagy
- ER stress & UPR
- JAK/STAT
- MAPK
- Cytoskeletal Signaling
- Cell Cycle
- TGF-beta/Smad
- 化合物ライブラリー
- FDA-approved Drug Library
- FDA-approved & Passed Phase I Drug Library
- Preclinical/Clinical Compound Library
- Bioactive Compound Library-I
- Bioactive Compound Library-II
- Kinase Inhibitor Library
- Express-Pick Library
- Natural Product Library
- Human Endogenous Metabolite Compound Library
- Covalent Inhibitor Library
- FDA-approved Anticancer Drug LibraryNew
- Highly Selective Inhibitor Library
- HTS Library for Drug Discovery
- Metabolism Compound Library
- 抗体
- 新製品
- お問い合わせ
Schisandrin A
別名：Deoxyschizandrin, Wuweizisu A
Schisandrin A (Sch A, Deoxyschizandrin, Wuweizisu A) is an active component of Schisandrae Fructus with liver-protective, antitumor, and antioxidant activities. It is an agonist of the adiponectin receptor 2 (AdipoR2) with the IC50 value of 3.5 μM.
CAS No. 61281-38-7
製品安全説明書
現在のバッチを見る：
S382201
DMSO]
83 mg/mL]
false]
]
]
false]
]
]
false
純度：
99.89%
99.89
Schisandrin A関連製品
AdipoR阻害剤の選択性比較
| 阻害剤 | Citation | 5-HT | 5-HT1 | 5-HT2 | 5-HT3 | 5-HT6 | 5-HT7 | 5-HT 1 | 5-HT1 | その他 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ketanserin | 4 | |||||||||
| RS-127445 | 4 | |||||||||
| WAY-100635 Maleate | 8 | |||||||||
| Blonanserin | 1 | dopamine D2 receptor | ||||||||
| BMY 7378 Dihydrochloride | 0 | α1D-adrenoceptor,Dopamine D2 receptor,α2C-adrenoceptor | ||||||||
| PRX-08066 Maleic acid | 1 | |||||||||
| SB742457 | 2 | |||||||||
| SB269970 HCl | 5 |
もっと見る
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.
生物活性
| 製品説明 | Schisandrin A (Sch A, Deoxyschizandrin, Wuweizisu A) is an active component of Schisandrae Fructus with liver-protective, antitumor, and antioxidant activities. It is an agonist of the adiponectin receptor 2 (AdipoR2) with the IC50 value of 3.5 μM. | ||
|---|---|---|---|
| Targets |
|
| In Vitro | ||||
| In vitro | Schisandrin A significantly suppresses the lipopolysaccharide (LPS)-induced production of the key pro-inflammatory mediators nitric oxide (NO) and prostaglandin E2 by suppressing the expression of inducible NO synthase and cyclooxygenase-2 at the mRNA and protein levels in RAW 264.7 macrophages. It is demonstrated to reduce the LPS-induced secretion of pro-inflammatory cytokines, including tumor necrosis factor-α and interleukin-1β; this is accompanied by a simultaneous decrease in the respective mRNA and protein levels in the macrophages. In addition, the LPS- induced translocation of nuclear factor-κB (NF-κB), as well as activation of mitogen-activated protein kinases (MAPKs) and phosphatidylinositol-3 kinase (PI3K)/Akt pathways are inhibited by schisandrin A. These results suggest that schisandrin A has a protective effect against LPS-induced inflammatory and oxidative responses in RAW 264.7 cells by inhibiting the NF-κB, MAPK and PI3K/Akt pathways. Schisandrin A possesses anti-inflammatory activities and excellent Nrf2-induction or ROS-scavenging abilities[2]. Schisandrin A can inhibit the replication of four serotypes of DENV in a concentration- and time-dependent manner, with an effective half-maximal effective concentration 50% (EC50) value of 28.1 ± 0.42 μM against DENV serotype type 2 without significant cytotoxicity[3]. | |||
|---|---|---|---|---|
| 細胞実験 | 細胞株 | The RAW 264.7 murine macrophage cell line | ||
| 濃度 | 0-200 μM | |||
| 反応時間 | 1 h | |||
| 実験の流れ | To evaluate the cytotoxicity of schisandrin A, RAW 264.7 cells are seeded in 96-well plates at a density of 1×103 cells/well. The cells are treated with various concentrations of schisandrin A for 1 h prior to incubation with LPS (100 ng/ml) for 24 h. After the incubation was complete, images of cells from each well are captured under a phase-contrast microscope. Subsequently, MTT is added to each well at 0.5 mg/ml, followed by incubation at 37°C in the dark. After 3 h of incubation, the MTT solution is removed and 200 μl 5% DMSO is added to dissolve the crystals. The viable cells are detected by reading the absorbance of formazan at 540 nm using an enzyme-linked immunosorbent assay (ELISA) microplate reader. The optical density of the formazan formed in the control (untreated) cells is considered to represent 100% viability. |
|||
| In Vivo | ||
| In Vivo | Schisandrin A has proven beneficial in preventing cell damage in the pathogenesis of central nervous system diseases, including ischemia[2]. Schisandrin A can effectively protect mice from DENV (Dengue virus) infection by reducing disease symptoms and mortality of DENV-infected mice. It stimulates IFN-mediated antiviral responses in vivo[3]. | |
|---|---|---|
| 動物実験 | 動物モデル | Male Kunming White mice |
| 投与量 | 1, 10, 20 mg/kg d | |
| 投与経路 | intragastrically administrated | |
化学情報
| 分子量 | 416.51 | 化学式 | C24H32O6 |
| CAS No. | 61281-38-7 | SDF | Download Schisandrin A SDFをダウンロードする |
| Smiles | CC1CC2=CC(=C(C(=C2C3=C(C(=C(C=C3CC1C)OC)OC)OC)OC)OC)OC | ||
| 保管 | |||
|
In vitro |
DMSO : 83 mg/mL ( (199.27 mM)； 吸湿したDMSOは溶解度を減少させます。新しいDMSOをご使用ください。) |
モル濃度計算器 |
実験計算
投与溶液組成計算機(クリア溶液)
ステップ１：実験データを入力してください。（実験操作によるロスを考慮し、動物数を1匹分多くして計算・調製することを推奨します）
mg/kg
g
μL
匹
ステップ２：投与溶媒の組成を入力してください。（ロット毎に適した溶解組成が異なる場合があります。詳細については弊社までお問い合わせください）
% DMSO
%
% Tween 80
% ddH2O
%DMSO
%
計算結果：
投与溶媒濃度： mg/ml;
DMSOストック溶液調製方法： mg 試薬を μL DMSOに溶解する（濃度 mg/mL, 注：濃度が当該ロットのDMSO溶解度を超える場合はご連絡ください。 )
投与溶媒調製方法：Take μL DMSOストック溶液に μL PEG300，を加え、完全溶解後μL Tween 80，を加えて完全溶解させた後 μL ddH2O，を加え完全に溶解させます。
投与溶媒調製方法：μL DMSOストック溶液に μL Corn oil，を加え、完全溶解。
注意：１.ストック溶液に沈殿、混濁などがないことをご確認ください；
２.順番通りに溶剤を加えてください。次のステップに進む前に溶液に沈殿、混濁などがないことを確認してから加えてください。ボルテックス、ソニケーション、水浴加熱など物理的な方法で溶解を早めることは可能です。
技術サポート
ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。
他に質問がある場合は、お気軽にお問い合わせください。
* 必須
Tags: Schisandrin Aを買う | Schisandrin A ic50 | Schisandrin A供給者 | Schisandrin Aを購入する | Schisandrin A費用 | Schisandrin A生産者 | オーダーSchisandrin A | Schisandrin A化学構造 | Schisandrin A分子量 | Schisandrin A代理店
納期
国内在庫品：受注日の翌日（15時までの受注分）
＊北海道、九州、沖縄への配送は受注日より２日以上
を要する場合あり
海外在庫品：受注後１〜２週間